Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Trial sample size, but not trial quality, is associated with positive study outcome
Journal of Clinical Epidemiology, 08/31/09
Singh JA et al. – Lack of association of reported trial quality with positive outcome in multivariable analyses suggests that previously observed association of reported study quality with study outcome in univariate analyses may be mediated by other study characteristics, such as study sample size.
Related Articles
Polymorphisms Identified through Genome-Wide Association Studies and Their Associations with Type 2 Diabetes in Chinese, Malays, and Asian-Indians in Singapore
Journal of Clinical Endocrinology and Metabolism, 11/18/09
Relevance Score: 65%
Family-based mitochondrial association study of traits related to type 2 diabetes and the metabolic syndrome in adolescents
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 10/12/09
Relevance Score: 65%
ADEPT - Abnormal Doppler Enteral Prescription Trial
BMC Pediatrics, 10/05/09
Relevance Score: 65%
Serum Soluble Interleukin-2 Receptor, Beta2-Microglobulin, Lactate Dehydrogenase and Erythrocyte Sedimentation Rate in Children with Hodgkin's Lymphoma
Scandinavian Journal of Immunology, 10/30/09
Relevance Score: 64%
Investigation of the association between CALCRL polymorphisms and primary angle closure glaucoma
Molecular Vision, 10/28/09
Relevance Score: 64%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
Cancer Chemotherapy and Pharmacology, 12/11/09
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/11/09
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


